Marvell projects strong fiscal 2028 revenue on AI-driven data center boom, shares jump

Marvell projects strong fiscal 2028 revenue on AI-driven data center boom, shares jump

By Jaspreet Singh March 5 (Reuters) – Marvell Technology (MRVL) forecast fiscal 2028 revenue above Wall Street estimates on Thursday, signaling strong demand for customized chips and interconnect options utilized in synthetic intelligence data facilities, sending its shares ‌surging 11% in premarket buying and selling on Friday. Growing adoption of AI tools has boosted demand…

Read More
J&J’s first-quarter profit beats estimates even as Stelara sales disappoint

J&J’s first-quarter profit beats estimates even as Stelara sales disappoint

By Michael Erman April 14 (Reuters) – Johnson & Johnson reported first-quarter earnings that beat Wall Street expectations on Tuesday and raised its full-year forecast, as robust demand for most cancers drug Darzalex and ‌psoriasis therapy Tremfya greater than offset a steep falloff in sales of its blockbuster autoimmune ‌drug Stelara. The drug and gadget…

Read More